CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
95.10
-0.10 (-0.11%)
Aug 15, 2025, 1:30 PM CST

CH Biotech R&D Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
364.31476.39463.29465.42291.5100.16
Upgrade
Depreciation & Amortization
201.64188.47164.34138.5195.3396.69
Upgrade
Other Amortization
1.291.291.481.181.321.51
Upgrade
Loss (Gain) From Sale of Assets
-0.39-0.31-1.07-0.57-0.11-0.04
Upgrade
Loss (Gain) on Equity Investments
1.420.260.05---
Upgrade
Stock-Based Compensation
--1.24---
Upgrade
Other Operating Activities
-24.89-65.5743.9813.0341.0510.94
Upgrade
Change in Accounts Receivable
-199.62-56.76-72.77127.84-124.69-4.85
Upgrade
Change in Inventory
-23.09-1.752.96-54.46-82.6413.03
Upgrade
Change in Accounts Payable
0.83-2.66-0.36-11.0913.944.39
Upgrade
Change in Unearned Revenue
0.1-0.140.17-0.05-0.15-0.48
Upgrade
Change in Other Net Operating Assets
-5.78-0.815.8519.1728.8111.55
Upgrade
Operating Cash Flow
326.23538.44659.15698.97264.36232.91
Upgrade
Operating Cash Flow Growth
-51.53%-18.31%-5.70%164.40%13.50%-23.75%
Upgrade
Capital Expenditures
-161.9-588.42-113.68-113.89-71.92-107.88
Upgrade
Sale of Property, Plant & Equipment
0.390.322.611.230.230.04
Upgrade
Cash Acquisitions
--3.55----
Upgrade
Sale (Purchase) of Intangibles
-4.15-1.54-1.04-3.26--0.87
Upgrade
Investment in Securities
---29.4---
Upgrade
Other Investing Activities
-13.19-1.58-1.38-1.3126.950.09
Upgrade
Investing Cash Flow
-178.85-594.77-142.89-117.22-44.75-108.63
Upgrade
Short-Term Debt Issued
-665.21480450381577
Upgrade
Long-Term Debt Issued
-413.3475.6595.6-714
Upgrade
Total Debt Issued
9351,079955.61,0463811,291
Upgrade
Short-Term Debt Repaid
--570.17-410-518-436-477
Upgrade
Long-Term Debt Repaid
--546.51-620.69-776.34-124.85-807.3
Upgrade
Total Debt Repaid
-848.08-1,117-1,031-1,294-560.85-1,284
Upgrade
Net Debt Issued (Repaid)
86.93-38.18-75.09-248.74-179.856.7
Upgrade
Issuance of Common Stock
0.170.1----
Upgrade
Common Dividends Paid
-421.48-369.05-473.77-126.63-42.21-88.44
Upgrade
Other Financing Activities
1.030.92442.26---
Upgrade
Financing Cash Flow
-333.36-406.21-106.6-375.37-222.06-81.74
Upgrade
Foreign Exchange Rate Adjustments
-5.481.460.252.64-0.55-0.52
Upgrade
Net Cash Flow
-191.45-461.08409.91209.01-342.03
Upgrade
Free Cash Flow
164.33-49.98545.47585.08192.43125.03
Upgrade
Free Cash Flow Growth
37.95%--6.77%204.04%53.91%-25.83%
Upgrade
Free Cash Flow Margin
9.76%-3.06%36.01%40.80%18.89%17.80%
Upgrade
Free Cash Flow Per Share
1.59-0.485.575.931.961.28
Upgrade
Cash Interest Paid
16.1614.9817.4116.1913.8722.7
Upgrade
Cash Income Tax Paid
102.1179.7476.1890.1827.2117.4
Upgrade
Levered Free Cash Flow
118.22-201.89446.3411.22111.187.82
Upgrade
Unlevered Free Cash Flow
128.21-192.52456.8421.73119.78102.03
Upgrade
Change in Working Capital
-227.57-62.07-14.1481.4-164.7423.64
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.